Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Celldex Therapeutics (CLDX) Revenue (2016 - 2025)

Historic Revenue for Celldex Therapeutics (CLDX) over the last 16 years, with Q2 2025 value amounting to $730000.0.

  • Celldex Therapeutics' Revenue fell 7077.66% to $730000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 7393.74%. This contributed to the annual value of $7.0 million for FY2024, which is 199.04% up from last year.
  • Per Celldex Therapeutics' latest filing, its Revenue stood at $730000.0 for Q2 2025, which was down 7077.66% from $695000.0 recorded in Q1 2025.
  • In the past 5 years, Celldex Therapeutics' Revenue ranged from a high of $4.1 million in Q4 2023 and a low of $153000.0 during Q3 2021
  • Its 5-year average for Revenue is $1.2 million, with a median of $712500.0 in 2025.
  • As far as peak fluctuations go, Celldex Therapeutics' Revenue skyrocketed by 137457.63% in 2021, and later crashed by 9531.61% in 2022.
  • Celldex Therapeutics' Revenue (Quarter) stood at $334000.0 in 2021, then skyrocketed by 382.93% to $1.6 million in 2022, then skyrocketed by 156.11% to $4.1 million in 2023, then crashed by 71.56% to $1.2 million in 2024, then plummeted by 37.87% to $730000.0 in 2025.
  • Its Revenue stands at $730000.0 for Q2 2025, versus $695000.0 for Q1 2025 and $1.2 million for Q4 2024.